Literature DB >> 25471039

miRNA detection methods and clinical implications in lung cancer.

Marta Usó1, Eloisa Jantus-Lewintre, Rafael Sirera, Roy M Bremnes, Carlos Camps.   

Abstract

Lung cancer is the leading cause of cancer death worldwide. Therefore, advances in the diagnosis and treatment of the disease are urgently needed. miRNAs are a family of small, noncoding RNAs that regulate gene expression at the transcriptional level. miRNAs have been reported to be deregulated and to play a critical role in different types of cancer, including lung cancer. Thus, miRNA profiling in lung cancer patients has become the core of several investigations. To this end, the development of a multitude of platforms for miRNA profiling analysis has been essential. This article focuses on the different technologies available for assessing miRNAs and the most important results obtained to date in lung cancer.

Entities:  

Keywords:  biomarker; diagnosis; lung cancer; miRNA; miRNA profiling; prognosis

Mesh:

Substances:

Year:  2014        PMID: 25471039     DOI: 10.2217/fon.14.93

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  6 in total

Review 1.  Exosomes genetic cargo in lung cancer: a truly Pandora's box.

Authors:  Pablo Reclusa; Rafael Sirera; Antonio Araujo; Marco Giallombardo; Anna Valentino; Laure Sorber; Ignacio Gil Bazo; Patrick Pauwels; Christian Rolfo
Journal:  Transl Lung Cancer Res       Date:  2016-10

Review 2.  MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknown.

Authors:  Maria Braoudaki; George I Lambrou
Journal:  J Hematol Oncol       Date:  2015-02-06       Impact factor: 17.388

3.  MicroRNA profiling associated with non-small cell lung cancer: next generation sequencing detection, experimental validation, and prognostic value.

Authors:  Sandra Gallach; Eloisa Jantus-Lewintre; Silvia Calabuig-Fariñas; David Montaner; Sergio Alonso; Rafael Sirera; Ana Blasco; Marta Usó; Ricardo Guijarro; Miguel Martorell; Carlos Camps
Journal:  Oncotarget       Date:  2017-06-22

4.  HSP90: A Novel Target Gene of miRNA-628-3p in A549 Cells.

Authors:  Jieli Pan; Fusheng Jiang; Jia Zhou; Dehong Wu; Zhenhua Sheng; Meiya Li
Journal:  Biomed Res Int       Date:  2018-05-20       Impact factor: 3.411

5.  Downregulation of microRNA-132 indicates progression in hepatocellular carcinoma.

Authors:  Xin Zhang; Wei Tang; Ruishan Li; Rongquan He; Tingqing Gan; Yihuan Luo; Gang Chen; Minhua Rong
Journal:  Exp Ther Med       Date:  2016-08-23       Impact factor: 2.447

Review 6.  Clinical Relevance of Liquid Biopsy in Melanoma and Merkel Cell Carcinoma.

Authors:  Magali Boyer; Laure Cayrefourcq; Olivier Dereure; Laurent Meunier; Ondine Becquart; Catherine Alix-Panabières
Journal:  Cancers (Basel)       Date:  2020-04-13       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.